Emtricitabine and rilpivirine and tenofovir only product in oral dose form
|
Product containing precisely emtricitabine 200 milligram and rilpivirine (as rilpivirine hydrochloride) 25 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet
Id1304319000
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSEmtricitabine
Has precise active ingredientEmtricitabine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSTenofovir disoproxil
Has precise active ingredientTenofovir disoproxil fumarate
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSRilpivirine
Has precise active ingredientRilpivirine hydrochloride
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg